These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16413845)
1. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Mohllajee AP; Curtis KM; Peterson HB Contraception; 2006 Feb; 73(2):145-53. PubMed ID: 16413845 [TBL] [Abstract][Full Text] [Related]
2. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings. Steen R; Shapiro K Reprod Health Matters; 2004 May; 12(23):136-43. PubMed ID: 15242222 [TBL] [Abstract][Full Text] [Related]
3. The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections. Jatlaoui TC; Simmons KB; Curtis KM Contraception; 2016 Dec; 94(6):701-712. PubMed ID: 27263041 [TBL] [Abstract][Full Text] [Related]
5. Intrauterine devices and pelvic inflammatory disease: an international perspective. Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812 [TBL] [Abstract][Full Text] [Related]
6. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard. Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955 [TBL] [Abstract][Full Text] [Related]
7. Does infection occur with modern intrauterine devices? Lancet; 1992 Mar; 339(8796):783-4. PubMed ID: 1347810 [TBL] [Abstract][Full Text] [Related]
8. Complications of use of intrauterine devices among HIV-1-infected women. Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743 [TBL] [Abstract][Full Text] [Related]
9. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Tepper NK; Steenland MW; Gaffield ME; Marchbanks PA; Curtis KM Contraception; 2013 May; 87(5):655-60. PubMed ID: 23040135 [TBL] [Abstract][Full Text] [Related]
11. The intrauterine device in the present and future. Rivera R; Chi IC; Farr G Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697 [TBL] [Abstract][Full Text] [Related]
12. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception. Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746 [TBL] [Abstract][Full Text] [Related]
13. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. Steenland MW; Zapata LB; Brahmi D; Marchbanks PA; Curtis KM Contraception; 2013 May; 87(5):611-24. PubMed ID: 23177264 [TBL] [Abstract][Full Text] [Related]
14. IUDs and PID: understanding the American situation. Netw Res Triangle Park N C; 1987; 8(2):8. PubMed ID: 12268660 [TBL] [Abstract][Full Text] [Related]
15. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
16. Pelvic inflammatory disease with intrauterine device use: a reassessment. Kessel E Fertil Steril; 1989 Jan; 51(1):1-11. PubMed ID: 2642807 [TBL] [Abstract][Full Text] [Related]
17. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement. Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886 [TBL] [Abstract][Full Text] [Related]